OBSEGONE
Live / Registered — Registered (as of 22 Sept 2026)
What this means for you
Registered since 22 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Sept 2032: the §71 affidavit of use).
Record
- Serial number
- 79435559
- Registration number
- 8445773
- Mark type
- Stylized text
- Filed
- 23 Apr 2025
- Published for opposition
- 04 Aug 2026
- Registered
- 22 Sept 2026
- Next maintenance filing
- §71 affidavit of use, due by 22 Sept 2032 (grace period to 22 Mar 2033)
- Attorney of record
- John H. Mutchler
Goods and services
- Class 005 — Pharmaceuticals: Drugs for medical purposes, namely, medical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); medical preparation for treating alcoholic fatty liver; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of alzheimer's disease; herbal tea for medical purposes; injectable medicinal solutions, namely, injectable pharmaceuticals for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); slimming pills; appetite suppressant pills; pharmaceutical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); cardiovascular pharmaceuticals for medical use; medicines for human purposes, namely, medicinal preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); appetite suppressants for medical purposes; biological preparations for medical purposes for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); medical preparations for slimming purposes; medical preparation for treating diabetes; slimming tea for medical purposes; antidiabetic pharmaceuticals; antidiabetic preparation; cardiovascular pharmaceutical preparations; lipotropic factor preparation; dietetic supplements adapted for medical use; diabetic bread adapted for medical use; dietetic beverages featuring fruit juices with pulp adapted for medical purposes, for use by diabetic patients
Owner
Prosecution history
- 22 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 04 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Aug 2026 — PUBLISHED FOR OPPOSITION
- 29 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Jul 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Jul 2026 — EXAMINER'S AMENDMENT ENTERED
- 02 Jul 2026 — EXAMINERS AMENDMENT E-MAILED
- 02 Jul 2026 — EXAMINERS AMENDMENT -WRITTEN
- 03 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Jan 2026 — REFUSAL PROCESSED BY IB
- 17 Dec 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 17 Dec 2025 — REFUSAL PROCESSED BY MPU